Vaishali Pharma Ltd

Vaishali Pharma, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching an all-time high of Rs. 214.89 on October 13, 2024. According to financial research firm MarketsMOJO, the stock call for Vaishali Pharma is currently 'Hold', indicating strong performance but not the best time to buy or sell. The company has outperformed its sector and market, with a consistent upward trend and a remarkable 1-year performance of 57.14%.

Vaishali Pharma, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on October 12th, 2024. The company's stock has been given a 'Hold' rating by MarketsMOJO and has outperformed the sector by 4.38%. With a remarkable growth of 57.14% in the past year, Vaishali Pharma is a strong player in the domestic market with a focus on research and development. Investors should do their own research and seek professional advice before investing.

Vaishali Pharma, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on October 11, 2024. The stock has been given a 'Hold' rating by MarketsMOJO and is currently trading at a price 0.75% away from its 52-week high. The company has outperformed the sector by 3.4% and is trading higher than its moving averages, indicating a positive trend. In the past year, Vaishali Pharma has shown a remarkable growth of 56.88%, outperforming the Sensex's performance of 22.51%.

Vaishali Pharma, a microcap pharmaceutical company, has reached an all-time high in its stock price on September 16, 2024. It has been given a 'Hold' rating by MarketsMOJO and is currently trading higher than its moving averages. Despite its small size, the company has shown strong growth and outperformed the sector.

Vaishali Pharma, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high of Rs. 212 on September 15, 2024. The company's stock is currently trading higher than its moving averages and has outperformed the Sensex in the past year, showcasing its strong growth and potential in the industry.

Vaishali Pharma, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high of Rs. 212 on September 14, 2024. According to financial research firm MarketsMOJO, the stock is currently rated 'Hold', in line with the overall pharmaceutical sector. Vaishali Pharma has outperformed the Sensex in the past year, showcasing its strong performance and potential for growth in the industry. With a focus on the pharmaceutical sector, the company has the potential to continue its upward trend and deliver value to investors.

Vaishali Pharma, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on September 13, 2024. Despite underperforming the sector today, the stock has consistently traded higher than its moving averages, indicating a positive trend. With a 65.46% increase in stock price in the past year, Vaishali Pharma has outperformed the Sensex, showcasing its strong financial performance and innovative products. Investors can consider holding onto their stocks as the company continues to make progress and expand its market presence.

Vaishali Pharma, a microcap pharmaceutical company, has reached an all-time high in its stock price on September 12, 2024. With a 'Hold' rating from MarketsMOJO, the stock is currently trading at a 0.74% premium to its 52-week high and has outperformed the pharmaceutical sector by 3.81%. This can be attributed to the company's strong presence in the industry and consistent efforts to deliver quality products.

Vaishali Pharma, a microcap pharmaceutical company, has reached an all-time high in its stock price on January 17th, 2024. Despite underperforming the sector today, the company has consistently traded above its moving averages and outperformed the Sensex in the past year. This indicates potential for growth in the pharmaceutical industry.

Vaishali Pharma, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on January 16th, 2024. With a 'Hold' rating from MarketsMOJO, the stock is currently trading above its moving averages and has outperformed the sector. Its strong performance and growth potential make it a company to watch in the pharma industry.

Vaishali Pharma, a microcap pharmaceutical company, has reached an all-time high stock price of Rs.196.7 on December 19, 2023. According to MarketsMOJO, the stock call for Vaishali Pharma is 'Hold', indicating its expected maintenance of current performance. The company has outperformed the sector by 3.44% today and is trading higher than its moving averages, showcasing its strong market position and potential for growth. In the past year, Vaishali Pharma has shown a remarkable growth of 28.40%, outperforming the Sensex's performance of 15.18%. With its consistent performance and strong financials, the company is poised for continued success in the future.